Patents
Patents for C07D 319 - Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms (10,283)
10/2000
10/12/2000DE10008505A1 New liquid crystal compounds, useful particularly in electro-optical display devices, contain sulfur tetrafluoride groups between six-membered rings
10/12/2000CA2369238A1 Cell adhesion-inhibiting antiinflammatory and immune-suppressive compounds
10/11/2000EP1043299A2 Liquid crystalline compound, liquid crystal composition comprising the liquid crystalline compound, and liquid crystal display device using the liquid crystal composition
10/11/2000EP1042290A1 Aromatic sulfone hydroxamic acid metalloprotease inhibitor
10/11/2000EP1042276A1 Thiourea and benzamide compounds, compositions and methods of treating or preventing inflammatory diseases and atherosclerosis
10/11/2000CN1269796A Monoacetals of bicyclohexyl-4,4-dione and their use in preparing liquid crystals
10/10/2000US6130243 1,4-benzodioxin derivatives
10/05/2000WO2000058301A1 N-[2-(4-aminophyl)ethyl]-2,3-dihydro-1,4-benzodioxine-2-methanamine, production and therapeutic use thereof
10/05/2000DE19918009A1 New trans-2,2,6,6-, -3,3,5,5-tetra- and 2,2,3,3,5,5,6,6-octa-fluorocyclohexyl compounds are used in liquid crystal medium in display or dielectric in electrooptical display, e.g. reflective or transflective display
10/05/2000DE10015255A1 New and known oxime derivatives used as photosensitive acid donors in chemically amplified photoresist compositions comprising a compound which is acid curable or which increases in solubility in acid
10/03/2000US6127372 Sulfonamide inhibitors of aspartyl protease
10/03/2000US6127357 N-((phenyl, benzodioxinyl or N-heteroarylpiperazinyl)alkyl)-N-(N-heteroaryl)substituted carboxamides
09/2000
09/30/2000CA2302875A1 Oxime derivatives and the use thereof as latent acids
09/27/2000EP1038863A2 Substituted dimeric compounds, process for their preparation and pharmaceutical compositions thereof
09/27/2000EP1037637A1 Use of 5ht1a receptor antagonists for preventing and/or treating temporal lobe epilepsy
09/26/2000US6124354 Arylcycloalkane carboxylic esters, their use, pharmaceutical compositions and preparation
09/26/2000US6124005 Fluoro-substituted alkyl ether compounds, liquid crystal compositions and liquid crystal display devices
09/21/2000WO2000004865A3 Synthetic techniques and intermediates for polyhydroxy, dienyl lactone derivatives
09/20/2000EP1035772A1 Fungicidal compositions and methods, and compounds and methods for the preparation thereof
09/19/2000US6121468 Process for producing amide derivatives and intermediate compounds
09/19/2000US6121466 Heating dicarboxylic acid (bis)glycol esters and glycol; catalysis, distillation
09/19/2000US6121304 Pentafluorobenzenesulfonamides and analogs
09/19/2000US6120696 Proton conductors in liquid form
09/19/2000CA2107484C New arylalkyl(thio)amides, their preparation process and pharmaceutical compositions containing them
09/14/2000WO2000053547A1 Method of preparing surface-active alcohols and surface-active alcoholic ethers, products obtained by said method and their use
09/14/2000DE19910370A1 Verfahren zur Herstellung von Tensidalkoholen und Tensidalkoholethern, die hergestellten Produkte und ihre Verwendung A process for the preparation of surfactant alcohols and surfactant alcohol ethers, the manufactured products and their use
09/12/2000US6117870 Cyclic amide derivatives
09/08/2000WO2000052002A1 N-substituted imide derivatives with serotonergic activity
09/08/2000CA2361182A1 N-substituted imide derivatives with serotonergic activity
09/06/2000CN1265658A 5-naphthalen-1-yl-1,3-dioxane derivatives, preparation and therapeutic application
09/05/2000US6114546 Aminomethylene derivatives and ultraviolet absorbent comprising thereof
09/05/2000US6114301 Detergent, cosmetic
08/2000
08/31/2000WO2000050415A1 Process for the preparation of glycerol carbonate
08/31/2000WO2000050390A1 N-substituted arylsulfonylamino hydroxamic acids useful as inhibitors of c-proteinase and for treating or preventing disorders related to unregulated collagen production
08/31/2000CA2364804A1 N-substituted arylsulfonylamino hydroxamic acids useful as inhibitors of c-proteinase and for treating or preventing disorders related to unregulated collagen production
08/30/2000EP1030840A1 Cyclic amine derivatives and their use as drugs
08/30/2000EP0749418B1 L-n6 -(1-iminoethyl)lysine derivatives useful as nitric oxide synthase inhibitors
08/29/2000US6110922 Cell adhesion-inhibiting antiinflammatory and immune-suppressive compounds
08/24/2000WO2000049014A1 Process for the production of tert-butyl (e)-(6-[2- [4-(4-fluorophenyl) -6-isopropyl-2-[ methyl (methylsulfonyl) amino] pyrimidin-5-yl] vinyl](4r, 6s)-2,2-dimethyl [1,3]dioxan-4-yl) acetate
08/24/2000WO1996012697A9 Calcium receptor-active compounds
08/23/2000EP0765926B1 Liquid-crystal composition and liquid-crystal display device
08/22/2000US6106908 Liquid crystalline (E, E)-butadiene compounds and mixtures and devices containing such compounds
08/17/2000WO2000047551A2 Inhibitors of aspartyl protease
08/16/2000EP1027043A1 Benzodioxole, benzofuran, dihydrobenzofuran, and benzodioxane melatonergic agents
08/16/2000CN1055468C Alkylaminoindane compounds process for preparing them and pharmaceutical compositions containing them,and use
08/15/2000US6103688 Aromatic compounds, processes for their preparation and their use in perfumery
08/15/2000US6103658 Olefin polymerization catalysts containing group 8-10 transition metals, processes employing such catalysts and polymers obtained therefrom
08/09/2000EP1026143A1 Novel liquid-crystal compounds having large negative value of permittivity anisotropy, liquid-crystal composition, and liquid-crystal display element
08/09/2000EP1026142A1 2,3-difluorophenyl derivatives having negative value of permittivity anisotropy, liquid-crystal composition, and liquid-crystal display element
08/09/2000EP1025082A1 Novel vitamin d derivatives with cyclopropyl rings in the lateral chains, a method and intermediate products for the production thereof and the utilization thereof for producing medicaments
08/09/2000EP1025079A1 $g(a)-ARYL-$i(N)-ALKYLNITRONES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME
08/09/2000CN1262618A NF-KB inhibitors containing as active ingredient phenylmethyl benzoquinone
08/08/2000US6100407 Process for producing simvastatin and/or its derivatives
08/08/2000US6100273 Water soluble camptothecin derivatives
08/03/2000WO2000044731A1 Novel hydroxyamidino carboxylate derivatives useful as nitric oxide synthase inhibitors
08/03/2000WO2000044473A1 Purification method of contaminated gases by dioxin and detrimental gas and the device therefor
08/03/2000DE19902879A1 Verfahren zur Herstellung von hochreinem Dilactid A process for the preparation of highly pure dilactide
08/02/2000EP1024139A1 Process for the preparation of optically active 2- 6-(hydroxymethyl)-1,3-dioxan-4-yl]acetic acid derivatives
08/02/2000EP1023260A1 Process for preparing beta-ketoester fragrance pro-accords from 1,3-dioxan-4,6-diones
08/01/2000US6096905 (e.g., a heavy ends residue obtained from purification) is contacted with a strong acid catalyst to produce a composition containing increased amounts of trimethylolalkane and trimethylolpropane monocyclic formal
08/01/2000US6096904 Discodermolides
08/01/2000CA2015034C Piperazine derivatives
07/2000
07/27/2000WO2000043382A1 Piperidine, tetrahydropyridine and piperazine derivatives, their preparation and use
07/27/2000WO2000043381A1 Method for producing high-purity dilactide
07/27/2000CA2361059A1 Piperidine, tetrahydropyridine and piperazine derivatives, their preparation and use
07/26/2000EP1021433A1 Method for producing natural diol-1,3 derivatives and corresponding natural 1,3-dioxane derivatives
07/26/2000EP1021410A1 Prostaglandin agonists and their use to treat bone disorders
07/26/2000EP1021403A2 2,3-dioxabicyclo 3.3.1]nonane derivatives and antimalarial pharmaceutical compositions comprising them
07/26/2000CN1054882C Enzymatic process for the stereoselective preparation of a hetero-bicyclic alcohol enantiomer
07/25/2000US6093742 Inhibitors of p38
07/20/2000WO2000041998A1 Novel propargylether derivatives
07/19/2000EP1020458A1 Optically active 1,4-benzodioxine-2-carboxylic acid derivatives and process for producing the same
07/19/2000EP1020423A1 Fluoroalkoxybenzene derivatives having ether bond, liquid-crystal composition, and liquid-crystal display element
07/19/2000CN1260789A Heterocyclic compounds, method for preparing and medicine compositions containing same
07/18/2000US6090954 Benzimidazole derivatives
07/18/2000US6090845 Hypotensive agent; vision defects
07/06/2000WO2000039081A2 Cell adhesion-inhibiting antiinflammatory and immune-suppressive compounds
07/06/2000WO2000039062A1 Liquid crystalline trifluoro-substituted compounds
07/06/2000WO2000018722A3 New derivatives of 6-(4-phenylbutoxy)hexylamine and process for producing salmeterol
07/05/2000EP1015443A1 Thromboxane ligands
07/05/2000EP1015420A1 Substituted alkenoic acids and their derivatives
07/05/2000EP1015412A1 Substituted alkenoic acids and their derivatives
07/04/2000US6083975 Administering to the patients a substituted 5-(2-((2-aryl-2-hydroxyethyl)amino)alkyl)-1,4-benzodioxin dicarbonyl compounds as antiobesity agent
06/2000
06/29/2000DE19959721A1 New vinyl-substituted mesogenic compounds, useful as components of liquid crystal compositions, provide good low temperature properties
06/29/2000DE19859684A1 Verfahren zur Herstellung von Fluor enthaltenden Phenethylaminen sowie neue, Fluor enthalende beta-Iminovinyl- und beta-Iminoethylbenzole A process for preparing fluorine-containing phenethylamines and new, fluorine enthalende beta-iminovinyl- and beta-iminoethylbenzenes
06/28/2000EP1013637A2 Process for the preparation of fluor containing phenethylamines and fluor containing beta-iminovinyl- and beta-iminoethylphenyl compounds
06/28/2000EP1012148A1 Monoacetals of bicyclohexyl-4,4-dione and their use in preparing liquid crystals
06/28/2000CN1258292A Olefin polymerization catalysts contg. group 8-10 transition metals, bidentate ligands, processes employing such catalysts and polymers obtained therefrom
06/27/2000US6080860 Urea compound where one of the urea nitrogens is part of an (un)substituted 5 or 6 membered ring and/or the other urea nitrogen is substituted with a 2-cyano-4,5-dialkoxyphenyl group; reacting with electrophile to form a leaving group
06/27/2000US6080781 Dissolving tetralone or benzopyranone compounds and a benzaldehyde compound in organic solvent, refluxing with heating under acidic condition and purifying the reactio product; useful for treating hormone dependent disease
06/27/2000US6080767 Substituted n-[(aminoiminomethyl or aminomethyl)phenyl]propyl amides
06/27/2000CA2110748C Process for the preparation of vitamin a and intermediate compounds useful in the process
06/23/2000CA2292851A1 Process for preparing fluorine-containing phenethylamines and novel fluorine-containing .beta.-iminovinyl-and .beta.-iminoethylbenzenes
06/22/2000WO2000035858A1 Phenylglycine derivatives
06/21/2000EP1010703A2 Process for preparing aryl metal compounds and their conversion with electrophiles
06/21/2000EP1010425A1 Remedies for irritable bowel syndrome
06/21/2000DE19958794A1 Liquid crystal media with positive dielectric anisotropy containing an additional component to give property improvements especially for reflective matrix displays
06/21/2000DE19858856A1 Verfahren zur Herstellung von Arylmetallverbindungen und deren Umsetzung mit Elektrophilen Process for the preparation of aryl metal compounds and reaction thereof with electrophiles
06/21/2000DE19857506A1 New liquid crystal cyanohydrin compounds with strongly negative dielectric anisotropy useful in various types of displays, obtained by conversion of ketones
06/21/2000DE19855757A1 Querverbrückte Cyclohexan-Derivate und flüssigkristallines Medium Cross-bridged cyclohexane derivatives and liquid crystalline medium
1 ... 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 ... 103